Pfizer CEO rules out generic COVID drug Paxlovid for China
Jan. 9 (Reuters) – Pfizer Inc (PFE.N) It’s not in talks with Chinese authorities to license a generic version of its COVID-19 treatment Paxlovid for use there, CEO Albert Bourla said Monday, but it is in discussions about the price of the branded product. Reuters reported on Friday that China is in talks with Pfizer … Read more